8 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| BEAM THERAPEUTICS INC. | 5 |
| BEAM THERAPEUTICS INC. | 3 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18486913 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BEAM THERAPEUTICS INC. | BREEN, KIMBERLY CATHERINE | 1657 | Non-Final OA | Oct 13, 2023 |
| 18474969 | ADENOSINE DEAMINASE VARIANTS AND USES THEREOF | BEAM THERAPEUTICS INC. | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | Sep 26, 2023 |
| 18031547 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | BEAM THERAPEUTICS INC. | YU, DAVID TUYANG | 1635 | Non-Final OA | Apr 12, 2023 |
| 17610119 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | BEAM THERAPEUTICS INC. | GIBBS, TERRA C | 1635 | Non-Final OA | Nov 09, 2021 |
| 17430669 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BEAM THERAPEUTICS INC. | REGA, KYLE THOMAS | 1636 | Non-Final OA | Aug 12, 2021 |
| 17430289 | SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE | BEAM THERAPEUTICS INC. | REGA, KYLE THOMAS | 1636 | Final Rejection | Aug 11, 2021 |
| 17430274 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | BEAM THERAPEUTICS INC. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Final Rejection | Aug 11, 2021 |
| 17054393 | METHODS OF SUPPRESSING PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS | BEAM THERAPEUTICS INC. | POPA, ILEANA | 1633 | Non-Final OA | Nov 10, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial